Danaher (DHR) has approved a regular quarterly cash dividend of 32c per share of its common stock, payable on April 25 to holders of record on ...

Leverage these to understand future stock performance and identify high performing investment ideas. You can also filter these to get relevant data aligned with your investing style and specific ...

Compared to the aggregate P/E ratio of the 95.78 in the Life Sciences Tools & Services industry, Danaher Inc. has a lower P/E ratio of 38.75. Shareholders might be inclined to think that the stock ...

D-Wave's valuation is climbing today after Microsoft unveiled its new quantum-computing chip. With today's gains, the quantum-computing specialist's stock is now up 292.5% over the last year.

JPMorgan lowered the firm’s price target on Ahold Delhaize (ADRNY) to EUR 25.42 from EUR 27.49 and keeps an Underweight rating on the ...

Danaher, Recursion Pharmaceuticals, Moderna, Thermo Fisher Scientific, AbbVie, Vertex Pharmaceuticals, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to ...

Veralto Corporation (NYSE: VLTO), a spin-off from Danaher Corporation (NYSE:DHR) with a market capitalization of $24.23 billion, has been navigating a complex market environment since its inception as ...

Washington, DC-based Danaher Corporation (DHR) is a leading global life sciences and diagnostics innovator, helping solve ...